SCHEMBL22600359

SCHEMBL22600359

CNc1cccc(CCCCCCC(=O)O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.60
RXFP1 Q9HBX9 1/20 0.60
LTB4R Q15722 4/20 0.51
TBXAS1 P24557 7/20 0.50
HDAC6 Q9UBN7 3/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC3 O15379 1/20 0.50
MAPK1 P28482 1/20 0.50
ADRA1A P35348 1/20 0.50
HDAC4 P56524 1/20 0.50
SLC6A3 Q01959 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
KDM4A O75164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11503362 0.98 MAPT (0.57) MAPTRXFP1LTB4RTBXAS1HDAC6
SCHEMBL12017476 0.87 FFAR1 (0.58) MAPTFFAR1
SCHEMBL5353446 0.85 MEN1 (0.63) MAPTRXFP1TBXAS1HDAC6HDAC1
SCHEMBL22600357 0.84 MAPT (0.55) MAPTRXFP1LTB4RTBXAS1HDAC6
SCHEMBL5106598 0.84 MEN1 (0.65) MAPTRXFP1HDAC6HDAC1HDAC3
SCHEMBL1197247 0.84 MAPT (0.78) MAPTRXFP1LTB4RTBXAS1HDAC6
SCHEMBL17846038 0.82 KMT2A (0.55) MAPTSMN1; SMN2
SCHEMBL25059243 0.81 NPC1 (0.47) MAPTHDAC6HDAC1HDAC3MAPK1
SCHEMBL16450752 0.81 MEN1 (0.56) HDAC6HDAC1HDAC3HDAC4SMN1; SMN2
SCHEMBL765851 0.80 MAPT (0.66) MAPTRXFP1LTB4RTBXAS1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200339596-A1 FUROXAN-BASED COMPOUNDS AND USES THEREOF UNIVERSITY OF MASSACHUSETTS 2020-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200339596-A1 FUROXAN-BASED COMPOUNDS AND USES THEREOF PARK7, HTT, PRDX5 MAPT 104/4885RXFP1 2398/4885LTB4R 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.